Arkolith/Insider Trading/AMLX/Form 4

Cohen Joshua B

Co-Chief Executive Officer, DirectorAmylyx Pharmaceuticals, Inc. (AMLX) · full profile →Form 4 · filed Jan 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$30K
Net Open-Market Flow
-$30K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2025Sell(S)7K$4.05$30K3.2M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-003531) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML